Get started
Author

C.K. Park

Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia
2012 · S Lee, S Lee, et al. · Leukemia · 112
Risk and prognostic factors for acute GVHD based on NIH consensus criteria
2012 · S-E Lee, B-S Cho, et al. · Bone Marrow Transplantation · 110
Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?
2013 · J-H Yoon, W-S Min, et al. · Bone Marrow Transplantation · 27
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure
2012 · S-H Shin, S-A Yahng, et al. · Bone Marrow Transplantation · 14
PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL
2014 · S-H Shin, J-H Yoon, et al. · Bone Marrow Transplantation · 5
Impact of Smoking and Decreased Lung Function on the Prognosis of Female Lung Cancer: Analysis of the Korean Association of Lung Cancer Registry
2020 · S.J. Kim, C.K. Park · CHEST Journal · 1
PDF
P2.03-16 TGF-β Induced EMT and Stemness Characteristics are Associated with Epigenetic Regulation in Lung Cancer
2018 · S.J. Kim, N. Kang, et al. · Journal of Thoracic Oncology · 1
PDF
56P: Initial analysis of a multicenter prospective and retrospective cohort study in EGFR-mutated non-small cell lung cancer patients in Korea
2025 · C.K. Park, S.J. Kim · Journal of Thoracic Oncology
PDF
59P Evaluating anticancer drug sensitivity in ALK-rearrangement-positive non-small cell lung cancer using the CODRP index-based test
2024 · S.J. Kim, S-H. Lee, et al. · ESMO Open
56P Rapid and accurate prediction of TKI treatment response in advanced EGFR-mutant non-small cell lung cancer using the CODRP platform
2024 · C.K. Park, S-H. Lee, et al. · ESMO Open
PDF
1305P Importance of the resected lung tumor specimen in patients with locally advanced and metastatic non-small cell lung cancer undergoing prior targeted therapy
2023 · J.U. Lim, J.W. Min, et al. · Annals of Oncology
PDF
P2.01-01 Association Between Clinical Outcomes and Local Treatment in Stage IV Non-small Cell Lung Cancer Patients with Single Extrathoracic Metastasis
2022 · S.J. Kim, J.U. Lim, et al. · Journal of Thoracic Oncology
PDF
P2.10-03 Prevalence of Tobacco Use Disorder in Patients Diagnosed with Lung Cancer and Their Tobacco Use Characteristics
2019 · C.K. Park, C.D. Yeo, et al. · Journal of Thoracic Oncology
PDF
P2.17-17 Clinical Effect of Adjuvant Chemotherapy on Stage IB NSCLC with High-Risk Factors
2019 · J. Choi, S.I. Choi, et al. · Journal of Thoracic Oncology
EP1.01-19 Updated Statistics of Never-Smoker Female Lung Cancer in Korea
2019 · S.J. Kim, C.K. Park, et al. · Journal of Thoracic Oncology
PDF
P1.01-076 Comparison of PANA Mutyper and PNA Clamping for Detecting KRAS Mutations in Tumor Tissue, Cell Block and Pleural Effusion from Cancer
2017 · C.K. Park, S.J. Kim, et al. · Journal of Thoracic Oncology
PDF
P1.03-025 Combination Therapy with Carboplatin and Hyperoxia Synergistically Enhances Suppression of Benzo[a]Pyrene Induced Lung Cancer
2017 · S.H. Lee, S.K. Kim, et al. · Journal of Thoracic Oncology
P3.01-057 Comparison of EGFR Mutations in Matched Tumor Tissues, Cell Blocks, Pleural Effusions and Bloods with NSCLC, by PANA Mutyper and PNA Clamping
2017 · S.J. Kim, C.K. Park, et al. · Journal of Thoracic Oncology
Works count: 18
Citation count: 270
H-index: 5
I10-index: 4
Year
Topic
Type